小分子调节器的α-synuclein相位分离
Debabrata Sarkar1, Sumangal Roychowdhury2, Rajeev Jain2,3
1Organic and Medicinal Chemistry Division, Indian Institute of Chemical Biology (CSIR-IICB), 4, Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India.
ACS chemical neuroscience
|August 7, 2025
概括
合成了新型的zwitherionic化合物,以抑制α-synuclein (α-Syn) 蛋白聚合,这是帕金森病 (PD) 病理学的关键因素. 这些化合物有效地降低了α-Syn液体-液体相分离和纤维素形成.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,由于大脑神经细胞受损,会影响运动控制.
- α-synuclein (α-Syn) 蛋白聚合和纤维化是PD病理学的核心标志.
- 液-液相分离 (LLPS) 和α-Syn的滴状形成越来越被认为是PD病变发生的关键.
研究的目的:
- 合成新型兹威特基化合物作为α-Syn聚合的潜在抑制剂.
- 研究这些化合物对α-Syn液态液相分离 (LLPS) 的作用.
- 评估化合物防止α-Syn纤维聚合物的形成的能力.
主要方法:
- 新型兹威特基化合物的合成.
- 在体外测试以评估α-Syn液态液相分离 (LLPS).
- 在合成化合物的存在下对α-Syn纤维素形成的分析.
主要成果:
- 成功合成了新型兹威特基化合物.
- 通过合成的化合物证明了α-Syn LLPS的度依赖抑制.
- 显著减少α-Syn纤维聚合物的形成.
结论:
- 新型兹维特里昂化合物有效地抑制α-Syn LLPS和随后的纤维细胞形成.
- 这些化合物代表了帕金森病的有希望的治疗策略.
- 通过LLPS抑制向α-Syn聚合是PD治疗的可行方法.
更多相关视频
08:40Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
3.0K
08:24A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
2.3K
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
